At closing bell, the 225-issue Nikkei Stock Average advanced 638.22 points, or 2.5%, to 26,165.59, reaching its highest since May 1991. The broader Topix index of all First Section issues on the Tokyo Stock Exchange added 35.01 points, or 2.03%, to 1,762.40. Japan share market closed on Monday for national holiday.
Total 32 sector sub-indexes of the 33 sector sub-indexes on the Tokyo exchange ended higher, with Securities & Commodities Futures, Precision Instruments, Iron & Steel, Metal Products, Real Estate, and Land Transportation sectors being notable gainers.
The Tokyo share markets commenced trading with firm footing on positive vaccine developments from AstraZeneca and the University of Oxford. The AstraZeneca (AZN) announced the its vaccine candidate being developed in collaboration with Oxford University had an average efficacy of 70%. The drug maker said one dosing regimen showed vaccine efficacy of 90% when given as a half dose, followed by a full dose at least one month apart, while another dosing regimen showed 62% efficacy when given as two full doses at least one month apart. This follows late-stage trial data from Pfizer-BioNTech and Moderna showing that their respective Covid-19 vaccines were around 95% effective.
The U.S. federal government recognized Biden as the apparent winner of the Nov. 3 election, giving the green light for cooperation on a transition of power despite efforts by President Donald Trump to overturn the election. Meanwhile, reports that Biden has chosen former Federal Reserve Chair Janet Yellen as treasury secretary, added to investors' confidence.
The stocks that gained the most among the top 30 core Topix names were Shin-Etsu Chemical Co Ltd up 4.42%, followed by Fanuc Corp gaining 3.67%. The underperformers among the Topix 30 were KDDI Corp down 0.76%, followed by Nintendo Co Ltd losing 0.09%.
CURRENCY NEWS: The U.S. dollar remained steady around the mid-104 yen zone following a firm tone on solid U.S. business activity data for November released overnight. The Japanese yen traded at 104.28 per dollar after seeing levels below 104 against the greenback yesterday.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
